2Johansson BW,Dziamski R. Malignant arrhythmias in acute myo- cardial infarction. Relationship to serum polassium and effect of se- lective and non - selective beta - blockade[J]. Drugs, 1984,28 (Suppl 1) :77 - 85.
3Kumar MS,Lu J ,Mercer KI., eT aL. lmpatred microRNA process- ing enhances cellular transformation and tumorigenesis[J].Nat Genet,2007,39(5):573 -677.
4Siddiqui A, Kowey PR. Sudden death secondary to cardiac arrhyth- mias: Mechanisms and treatment strategies[J]. Curr Opin Cardiol, 2006,21(5):517 - 525.
4Greene HL,Roden DM,Katz RJ,Woosley RL,Salerno DM,Henthorn RW.The Cardiac Arrhythmia Suppression Trial:first CAST then CAST II[J].J Am Coll Carciol,1992,19∶894-898.
5Podrid PJ.Amiodarone:reevaluation of an old drug[J].Ann Intern Med,1995,122∶689-700.
6Roden DM.Pharmacokinetics of amiodarone:implications for drug therapy[J].Am J Cardiol,1993,72∶45F-50F.
7Singh BN,Venkatesh N,Nademanee K,et al.The historical development,cellular electrophysiology,and pharmacology of amiodarone[J].Prog Cardovasc D S,1989,31∶249-280.
8Singh BN,Nademanee K.Amiodarone and thyroid function:clirical implications during antiarrhythmic therapy[J].Am Heart J,1983,106∶857-869.
9Nattle S.Comparative mechanisms of action of antiarrhythmic drugs[J].Am J Cardiol,1993,72(16)∶13F-17F.
10The CASCADE investigators:The Cascade study-randomized anti-arrhythmic drug therapy in survivors of cardiac arrest in Seattle[J].Am J Cardiol,1993,13∶442-449.
